XML 14 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities    
Net income (loss) $ (45,878) $ (125,878)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation expense 12,368 13,533
Noncash lease expense 3,992 3,985
Share-based compensation expense 38,763 40,778
Intangible assets amortization 1,270 1,275
Investment amortization (2,224) (6,750)
Impairment of long-lived assets 0 7,205
Inventory reserve (52) 1,446
Noncash interest expense (1,441) 2,039
Other 477 153
Changes in operating assets and liabilities    
Accounts receivable, net (3,102) (2,845)
Inventory (988) 1,990
Prepaid expenses and other current assets (2,532) (877)
Accounts payable and accrued liabilities (500) (3,593)
Operating lease right-of-use assets and liabilities (7,797) (6,418)
Deferred revenue (40,402) (8,786)
Other 5 22
Net cash used in operating activities (48,041) (82,721)
Investing activities    
Purchases of property and equipment (2,323) (3,584)
Purchases of marketable securities (134,983) (199,458)
Proceeds from maturities of marketable securities 183,508 258,715
Net cash provided by investing activities 46,202 55,673
Financing activities    
Proceeds from exercise of stock options 8,745 114
Net cash provided by financing activities 8,745 114
Net increase (decrease) in cash, cash equivalents and restricted cash 6,906 (26,934)
Cash, cash equivalents and restricted cash at beginning of year 50,817 67,996
Cash, cash equivalents and restricted cash at end of period 57,723 41,062
Noncash investing activities    
Purchases of equipment included in accounts payable and accrued liabilities 668 29
Supplemental disclosure of cash flow information    
Cash paid for interest $ 7,939 $ 6,542